Advancing dementia-friendly hospital care: a systematic review of healthcare professionals' reported barriers and facilitators using the theoretical domains framework
Abstract
Background: People living with dementia are common in hospitals and often experience poorer outcomes, yet dementia-friendly hospital care (DFHC) is not consistently embedded in routine practice. A theory-informed synthesis of healthcare professionals' reported barriers and facilitators is needed to guide implementation.
Objectives: To synthesise healthcare professionals' reported barriers and facilitators to DFHC using the Theoretical Domains Framework (TDF).
Methods: We conducted a systematic review of peer-reviewed studies published between 2015 and 2025. MEDLINE, CINAHL, PsycINFO and EMBASE were searched, with citation tracking. Eligible studies reported staff-reported barriers and/or facilitators relevant to DFHC in hospital settings. Two reviewers independently screened, extracted and appraised studies using the Mixed Methods Appraisal Tool. Determinants were classified as barriers or facilitators and mapped to TDF domains; recurrent cross-domain bundles were identified inductively. The review was registered in PROSPERO (CRD420251085854).
Results: Sixty-five studies were included. Methodological quality was generally high. We coded 856 determinants: 455 barriers and 401 facilitators. Barriers were most commonly mapped to Environmental Context and Resources (14.1%), Knowledge (12.5%) and Social Influences (11.0%). Facilitators clustered mainly in Social Influences (15.2%), Environmental Context and Resources (15.0%), and Knowledge (14.2%). Recurrent barrier bundles…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.